Galectin-3 Functions as an Alarmin: Pathogenic Role for Sepsis Development in Murine Respiratory Tularemia

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mishra, Bibhuti B ^a   Li, Qun ^b   Steichen, Anthony L ^a   Binstock, Brandilyn J ^a   Metzger, Dennis W ^c   Teale, Judy M ^b   Sharma, Jyotika ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; CYTOKINE; GALECTIN 3; HOST FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; FEMALE; FRANCISELLA; FRANCISELLA NOVICIDA; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RESPIRATORY TRACT INFECTION; RESPIRATORY TULAREMIA; SEPSIS; TULAREMIA; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GALECTIN 3; IMMUNOLOGIC FACTORS; IN SITU NICK-END LABELING; KAPLAN-MEIER ESTIMATE; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; SEPSIS; TULAREMIA;

EID: 84875157995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059616     Document Type: Article

References (55)

1. Namas R, Zamora R, An G, Doyle J, Dick TE, et al. (2012) Sepsis: Something old, something new, and a systems view. J Crit Care 27(3): 314.e1-11.
2. Hotchkiss RS, Karl IE, (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
3. Sharma J, Li Q, Mishra BB, Pena C, Teale JM, (2009) Lethal pulmonary infection with Francisella novicida is associated with severe sepsis. J Leukoc Biol 86: 491-504.
4. Sharma J, Li Q, Mishra BB, Georges MJ, Teale JM, (2009) Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis. Infect Immun 77: 4314-4326.
5. Sharma J, Li Q, Mishra BB, Teale JM, (2009) Lethal pulmonary infection with Francisella novicida causes depletion of alphabeta T cells from lungs. Cell Immunol 257: 1-4.
6. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, et al. (2006) Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun 74: 6730-6738.
7. Sharma J, Mares CA, Li Q, Morris EG, Teale JM, (2011) Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain. Microb Pathog 51: 39-47.
8. Wickstrum JR, Bokhari SM, Fischer JL, Pinson DM, Yeh HW, et al. (2009) Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice. Infect Immun 77: 4827-4836.
9. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM, (2008) Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 76: 3001-3010.
10. Mares CA, Sharma J, Ojeda SS, Li Q, Campos JA, et al. (2010) Attenuated response of aged mice to respiratory Francisella novicida is characterized by reduced cell death and absence of subsequent hypercytokinemia. PLoS One 5: e14088.
11. Mares CA, Sharma J, Li Q, Rangel EL, Morris EG, et al. (2011) Defect in efferocytosis leads to alternative activation of macrophages in Francisella infections. Immunol Cell Biol 89: 167-172.
12. Bianchi ME, (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
13. Oppenheim JJ, Yang D, (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17: 359-365.
14. Manson J, Thiemermann C, Brohi K, (2012) Trauma alarmins as activators of damage-induced inflammation. Br J Surg 99 (Suppl 1): 12-20.
15. Rittirsch D, Flierl MA, Ward PA, (2008) Harmful molecular mechanisms in sepsis. Nat Rev Immunol 8: 776-787.
16. Lamkanfi M, Dixit VM, (2011) Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187: 597-602.
17. Cerliani JP, Stowell SR, Mascanfroni ID, Arthur CM, Cummings RD, et al. (2011) Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J Clin Immunol 31: 10-21.
18. Cooper D, Iqbal AJ, Gittens BR, Cervone C, Perretti M, (2012) The effect of galectins on leukocyte trafficking in inflammation: sweet or sour? Ann N Y Acad Sci 1253: 181-192.
19. Liu FT, Patterson RJ, Wang JL, (2002) Intracellular functions of galectins. Biochim Biophys Acta 1572: 263-273.
20. Sato S, St-Pierre C, Bhaumik P, Nieminen J, (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-187.
21. Li Y, Komai-Koma M, Gilchrist DS, Hsu DK, Liu FT, et al. (2008) Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol 181: 2781-2789.
22. Lopez E, del Pozo V, Miguel T, Sastre B, Seoane C, et al. (2006) Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 176: 1943-1950.
23. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, et al. (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23: 313-320.
24. Gundra UM, Mishra BB, Wong K, Teale JM, (2011) Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect Immun 79: 2586-2596.
25. Gonzalez-Juarrero M, Orme IM, (2001) Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect Immun 69: 1127-1133.
26. Mariathasan S, Weiss DS, Dixit VM, Monack DM, (2005) Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202: 1043-1049.
27. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22: 238-244.
28. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76: 5843-5852.
29. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
30. Fry DE, (2012) Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 78: 1-8.
31. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, et al. (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81: 59-66.
32. Wheeler DS, Lahni P, Odoms K, Jacobs BR, Carcillo JA, et al. (2007) Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock. Inflamm Res 56: 216-219.
33. Foell D, Wittkowski H, Ren Z, Turton J, Pang G, et al. (2008) Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 216: 183-192.
34. Dagher SF, Wang JL, Patterson RJ, (1995) Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 92: 1213-1217.
35. Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, et al. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86: 655-662.
36. Berthelot F, Fattoum L, Casulli S, Gozlan J, Marechal V, et al. (2012) The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration. J Innate Immun 4: 41-58.
37. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, et al. (2002) Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunol 168: 1813-1822.
38. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, et al. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181: 4666-4675.
39. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, et al. (2003) Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171: 2602-2609.
40. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A, (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
41. Schwartz JT, Barker JH, Kaufman J, Fayram DC, McCracken JM, et al. (2012) Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan. J Immunol 188: 3351-3363.
42. Alves CM, Silva DA, Azzolini AE, Marzocchi-Machado CM, Carvalho JV, et al. (2010) Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early Toxoplasma gondii infection. Immunobiology 215: 475-485.
43. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, et al. (2000) Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 156: 1073-1083.
44. Mizgerd JP, (2006) Lung infection-a public health priority. PLoS Med 3: e76.
45. Mizgerd JP, (2008) Acute lower respiratory tract infection. N Engl J Med 358: 716-727.
46. Fink MP, (2001) Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17: 219-237.
47. Riedemann NC, Guo RF, Ward PA, (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524.
48. John CM, Jarvis GA, Swanson KV, Leffler H, Cooper MD, et al. (2002) Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected. Cell Microbiol 4: 649-662.
49. Kleshchenko YY, Moody TN, Furtak VA, Ochieng J, Lima MF, et al. (2004) Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infect Immun 72: 6717-6721.
50. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG, (2006) Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 177: 4718-4726.
51. Pelletier I, Sato S, (2002) Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope. J Biol Chem 277: 17663-17670.
52. Alleva LM, Budd AC, Clark IA, (2008) Systemic release of high mobility group box 1 protein during severe murine influenza. J Immunol 181: 1454-1459.
53. Yang H, Ochani M, Li J, Qiang X, Tanovic M, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101: 296-301.
54. Suda K, Kitagawa Y, Ozawa S, Saikawa Y, Ueda M, et al. (2006) Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg 30: 1755-1762.
55. Pani B, Ong HL, Liu X, Rauser K, Ambudkar IS, et al. (2008) Lipid rafts determine clustering of STIM1 in endoplasmic reticulum-plasma membrane junctions and regulation of store-operated Ca2+ entry (SOCE). J Biol Chem 283: 17333-17340.